Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Inventory Average (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Inventory Average for 13 consecutive years, with $19.6 million as the latest value for Q4 2025.

  • Quarterly Inventory Average rose 98.7% to $19.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $19.6 million through Dec 2025, up 98.7% year-over-year, with the annual reading at $14.8 million for FY2025, 24.87% up from the prior year.
  • Inventory Average for Q4 2025 was $19.6 million at Niagen Bioscience, up from $16.6 million in the prior quarter.
  • The five-year high for Inventory Average was $19.6 million in Q4 2025, with the low at $9.9 million in Q4 2024.
  • Average Inventory Average over 5 years is $13.5 million, with a median of $13.2 million recorded in 2021.
  • The sharpest move saw Inventory Average dropped 27.3% in 2024, then soared 98.7% in 2025.
  • Over 5 years, Inventory Average stood at $13.1 million in 2021, then grew by 15.36% to $15.2 million in 2022, then dropped by 10.44% to $13.6 million in 2023, then decreased by 27.3% to $9.9 million in 2024, then skyrocketed by 98.7% to $19.6 million in 2025.
  • According to Business Quant data, Inventory Average over the past three periods came in at $19.6 million, $16.6 million, and $12.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.